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Abstract To diagnose dogs infected by Leishmania infantum rK39 rapid diagnosis test is widely used in
 the Americas, while dual path platform (DPP) was recently adopted by Brazil. In this study we 
assessed the performance of rK39-RDT and DPP tests in recent urban transmission scenarios of Argentina. 
The sensitivity and specificity were evaluated with a sera panel and field samples, taken as true infected those 
from parasitological and/or PCR positive tests. Since none of these tests can be taken as a gold standard, the 
performance was also evaluated using Latent Class Analysis, a statistical modeling technique which allows to 
estimating sensitivity and specificity defining a latent class variable as the reference standard. The sensitivity 
of both tests in the panel was around 92% (symptomatic dogs 96%, asymptomatic 83%), while the sensitivity 
in field samples of rK39-RDT was 77%, and DPP 98% (mean in symptomatic dogs 89%, asymptomatic 82%). 
The specificity was similar for both tests and samples, around 98%. Therefore, these tests are acceptable for 
program dog population-based studies, as spatial stratification, focus intervention and follow up, and they could 
be used for individual screening and confirmation of clinical presumptive diagnosis in polysymptomatic dogs. 
The inability to discriminate between immunity and actual infectiousness suggest that a combination with other 
non-immunological based tests will be required for highly sensitive/specific diagnosis in order to targeting control 
measures in individual reservoirs from public health perspective, as for individual management from animal health 
perspective. 
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Resumen Desempeño de pruebas diagnósticas rápidas para leishmaniosis visceral canina en Argentina.
 Para diagnosticar perros infectados por Leishmania infantum, en las Américas se utiliza ampliamente 
la prueba rápida rK39, mientras que DPP fue adoptado recientemente por Brasil. En este estudio se evaluó el 
desempeño de las pruebas rK39-RDT y DPP en escenarios de transmisión urbana reciente en Argentina. La 
sensibilidad y especificidad se evaluaron con un panel de sueros y muestras de campo, considerando muestras 
infectadas verdaderas aquellas con pruebas parasitológicas y/o de PCR positivas. Como ninguna de estas pruebas 
puede considerarse estándar de oro, el desempeño también se evaluó mediante análisis de clases latentes, una 
técnica de modelado estadístico que permite estimar sensibilidad y especificidad definiendo una variable de clase 
latente como estándar. La sensibilidad de ambas pruebas en el panel fue de alrededor del 92% (perros sintomá-
ticos 96%, asintomáticos 83%), mientras que la sensibilidad en muestras de campo fue rK39-RDT: 77%, y DPP 
98% (media en perros sintomáticos 89%, asintomáticos 82%). La especificidad fue similar para ambas pruebas 
y muestras, cerca de 98%. Por lo tanto, estas pruebas son aceptables para estudios programáticos caninos de 
base-poblacional, como estratificación espacial, intervención de foco y seguimiento, y podrían utilizarse para el 
tamizaje individual y la confirmación del diagnóstico clínico presuntivo en perros poli-sintomáticos. La incapacidad 
de discriminar entre inmunidad e infectividad real sugiere que se requerirá una combinación con otras pruebas, 
de base no inmunológica, para un diagnóstico suficientemente sensible/específico que permita definir las medidas 
de control en reservorios individuales, tanto para salud pública, como para la gestión individual en salud animal. 
Palabras clave: diagnóstico, prueba inmunológica, vigilancia poblacional, leishmaniasis canina 
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Visceral leishmaniasis is a neglected vector-borne 
disease with an estimated worldwide annual incidence 
of 200 000 to 400 000 cases, and a case-fatality rate of 
10%1. Leishmania infantum is the etiological agent of the 
disease in the Americas, with Lutozmyia longipalpis as its 
main vector. The cases of Brazil account for 96% of the 
human visceral cases of the Americas, but an increasing 
incidence and expansion of transmission in Argentina, 
Colombia, Paraguay and Venezuela were reported dur-
ing the last decades2. In Argentina the urban vector was 
recorded for the first time in 2004, the first human case in 
2006, and after that the vector spread to five provinces, 
and human cases to four provinces. This trend is due to 
the process of urbanization and expansion that started 
in Brazil during 1970-19803. The dog, despite its clinical 
status (asymptomatic to polysymptomatic), is the main 
urban reservoir of parasites transmitted both to dogs and 
humans through the bite of an infected vector. But there 
is also a dog to dog reservoir by dog vertical and sexual 
transmission. Therefore, the accurate diagnosis of ca-
nine visceral leishmaniasis (CVL) became a critical ‘One 
Health’ issue for human public health, and for individual 
and collective animal health. 
Many immuno-serological and molecular diagnostic 
tests have been proposed and even are commercially 
available4. However, in order to assess its performance, 
the aim of any new test should be defined: a) for control 
programs: population-based surveillance screening 
of reservoirs, cohort studies and impact assessment, 
individual-based management decision, identification of 
super-spreaders; b) for the veterinarian perspective and 
research: diagnosis for case management, biomarkers of 
disease prognosis, molecules for vaccine development 
and evaluation of effectiveness of treatment.
 Since December 2011, the Brazilian Ministry of 
Health, requires for CVL immunoserodiagnosis, in the 
Surveillance and Control Program of Leishmaniasis, the 
dual-path platform DPP® rapid test for screening, with 
an enzyme-linked immunosorbent assay (ELISA) using 
soluble antigens of L. infantum as confirmatory test 5. 
Argentina Leishmaniasis’ Program use Kalazar DetectTM 
for CVL diagnosis, a rK39 dipstick rapid test commer-
cially available with a recombinant protein of L.infantum, 
which is also contained in the modified rK28 DPP test. 
Both rapid tests were compared in Brazil showing that 
the results could depend on the transmission scenario 
intensity6. 
Therefore, we performed a study to assess the perfor-
mance of both tests in the relatively new foci of Argentina, 
in the southern latitudes of CVL spread, with a controlled 
sera panel and with field sampled dogs from an endemic 
city, so with a broad spectrum of immune responses to 
infection. The results can be useful to compare the Brazil-
ian studies with those of other countries, mainly in border 
areas, to evaluate the usefulness of the DPP outside 
Brazil, but also to analyze the advantages and limitations 
of an immune-serological rapid tests for CVL diagnosis. 
Materials and methods 
Serological Qualitative Rapid Diagnostic Tests: a) rK39-RDT: 
Kalazar DetectTM (InBios, Inc., Seattle, WA, USA) kit for CVL. 
It is based on a 39 amino acid repeat immunodominant B-
cell epitope in a kinesin-related protein, which is conserved 
between L. infantum and L. donovani. b) DPP: Dual-path 
platform fast test (TR DPP®kit for CVL (Bio-Manguinhos, Rio 
de Janeiro, Brazil). It is a colloidal gold-based immunochro-
matography assay with a recombinant chimeric protein (rK28) 
multi-epitope from the fusion of L. infantum genes: k9, single 
repeat units of k39 and k267. 
Parasitological test: Samples were taken by a popliteal 
lymph node puncture with a hypodermic needle; smears were 
fixed with methanol and stained with May-Grünwald-Giemsa. 
Routine analysis involved the observation of two hundred 
microscopical fields, or until the identification of at least one 
amastigote. 
PCR tests: a) Sample genome quality was evaluated with 
protocol targets the CytB gene of vertebrates (CytB1 5´-CCC 
CTC AGA ATG ATA TTT GTC CTC A-3´ and CytB2 5´-CCA 
TCC AAC ATC TCA GCA TGA TGA AA-3´). Human genome of 
a healthy donor was employed as positive control. b) Leishma-
nia was detected using a standardized protocol targeting the 
ribosomal internal transcribed spacer (ITS-1) of Leishmania 
sp. (LITSR 5´-CTG GAT CAT TTT CCG ATG-3´ and L5.8S 
5´-TGA TAC CAC TTA TCG CAC TT-3´)8. Leishmania (V.) 
braziliensis reference strain (MHOM/BR/1975/2903) was em-
ployed as positive control. PCRs were carried out with 5 μl of 
extracted DNA in a final volume of 50 μl containing 1× PCR 
buffer (200mM Tris-HCl, pH 8), 0.1mM EDTA, 1mM DTT, 50% 
glycerol (v/v) (Invitrogen™), 2 mM MgCl2 (Invitrogen™), 2.5% 
DMSO (SIGMA™), 0.2 mM dNTP Mix, 0.5 μM of each primer, 
and 1.4 U Taq polymerase (Invitrogen™). Up to 10 μl of the 
amplified products were analyzed by 2% agarose gel electro-
phoresis at 5 V/cm, stained with SYBR Safe™ (0.5 μg/ml) and 
visualized with a Safe Imager™ 2.0 Blue-Light Transilluminator 
(470 nm). For ITS-1 positive samples PCR was followed up by 
a RFLP assay for Leishmania strain identification, or amplicons 
sequenced using Macrogen Inc. service (Korea). Edition and 
alignment of the sequencer AB1 files were performed with 
Codon Code™ v 3.0.1 (CodonCode Corporation). Leishmania 
strain sequence homology was considered when the value 
retrieved by Blast (Basic Local Alignment Tool) was over 99% 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi).
The panel (n = 431) involves the following sera samples 
categories: i) Infected dogs from the endemic area with posi-
tive parasitological test from popliteal lymph node smear or 
positive PCR (Origin: Posadas city, Argentina). ii) Positive in-
conclusive dogs from visceral leishmaniasis endemic area with 
negative parasitological test of popliteal lymph node smear but 
positive rK39-RDT (Posadas city). iii) Negative, dogs from the 
endemic area with negative parasitological test from popliteal 
lymph node smear, negative PCR, and negative rK39-RDT 
(Posadas city). iv) Non-infected, clinically healthy dogs from 
a non-endemic VL area (Buenos Aires city, Argentina). v) 
Non-infected, other infections dogs from non-endemic areas, 
with infections of Trypanosoma cruzi (n = 50), Leptospira sp. 
(n = 13), Dirofilaria sp (n = 10), demodicosis by Demodex 
sp. (n = 3) and Brucella sp. (n = 1) (Table 1). Samples were 
further discriminated according the dog donor clinical status 
as: a) Asymptomatic, not presented any clinical sign of CVL 
disease. b) Symptomatic, presented lymphadenopathy to-
gether with other clinical sign, like onychogryphosis, cutaneous 
PERFORMANCE OF DPP AND RK39 FOR CVL 105
TABLE 1.– Canine sera panel for performance evaluation of DPP and rK39-RDT
tests for canine visceral leishmaniasis diagnosis
Group Area of origin Characteristics n Symptomatic n (%)
Infected Endemic Parasitological or PCR positive 89 60 (67.4%) 
Positive inconclusive Endemic Parasitological negative, rK9-RDT positive 73 34 (46.6%)
Negative Endemic Parasitological, PCR and rK39-RDT negative 91 45 (49.5%)
Non-infected non-endemic  101
 non-endemic Potential cross-reactivity  77
Total   431
lesions, weight loss, conjunctivitis, alopecia or apathy. None 
dogs received leishmaniasis vaccine. The dogs were tested 
by optical parasitological diagnosis from popliteal lymph node 
smears and PCR from splenic aspirates as described in the 
section parasitological test, and DPP and rK39-RDT diagnostic 
test kits were used in accordance with manufacturer’s recom-
mendations. Test readers were blinded to the clinical status of 
the dog, and the results of other diagnostic tests.
Dogs were sampled during September 2013, in Oberá city 
(Argentina), an endemic area for CVL with antecedents of 
human visceral cases, in the neighborhoods of Villa Erasmie 
and Cien hectáreas, identified by the local agent of zoonosis 
as sectors with high density of canine presumptive cases. 
Dwellings were selected by systematic random sampling, 
and in each dwelling all the dogs were sampled (n = 563). All 
sampled dogs were owned, and no samples from stray dogs 
were collected. The dogs were examined for clinical signs of 
CVL (categories as in the section above) and the symptoms 
recorded. None dogs received leishmaniasis vaccine. Popli-
teal lymph node aspirates and blood samples (venipuncture 
of the jugular or the cephalic) were collected regardless the 
clinical status, using disposable syringes and needles, sera 
were separated by centrifugation, and processed 3-4 h after 
collection for the rapid tests. DPP and rK39-RDT diagnostic 
test kits were used in accordance with manufacturer’s recom-
mendations. In addition, when the volume of the sample ob-
tained from popliteal lymph node aspirates allowed it (n = 118), 
smears-parasitological direct tests and PCR were carried out. 
For this last purpose the samples in 200 μl of phosphate buf-
fer solution pH7.0 were kept cool in the field until they were 
frozen at -20 °C.
We compared DPP and rK39-RDT results of the sera 
panel between infected and non-infected groups (n = 267). 
In order to compute the sensitivity and specificity we used a 
positive parasitological and/or PCR results as true infected. 
However, as a gold standard with high specificity but low 
sensitivity could underestimate the true specificity of the tests 
evaluated, we performed also a Latent Class Analysis (LCA), 
a statistical modeling technique recommended in absence of 
an acceptable gold standard, and previously used for canine 
leishmaniasis9-11. We used the results of the DPP, rK39-RDT 
and parasitological tests (n = 431) to define a non-observable 
(latent) variable indicating the true disease status of the 
sample10. The goodness of fit of the statistical model was 
evaluated using the likelihood-ratio statistic G2 and entropy 
R2. DPP was also evaluated using rK39-RDT as reference 
standard (n = 431). The sensitivity and specificity for DPP and 
rK39-RDT of the sera panel and samples for field performance 
were estimated using 95% confidence interval (CI). In order to 
compare sensitivities and specificities the McNemar’s test was 
employed, with a significance level of 0.05. The agreement 
between the results obtained with the rapid tests was assessed 
using the Cohen’s Kappa statistic: no agreement (< 0), slight 
(0-0.20), fair (0.21-0.40), moderate (0.41-0.60), substantial 
(0.61-0.80), and perfect-almost perfect agreement (0.81-1). 
The statistical analyses were performed using Stata™ software 
(version 13.1; Stata Corp, College Station, TX). Latent class 
analysis was performed using the LCA Stata Plugin™ (Version 
1.2; University Park: The Methodology Center, Penn State).
Field procedures and handling of dogs were performed 
according to the protocol and informed approved by the Eth-
ics Committee of the Fatala Chaben Institute and complies 
with National regulations and OIE recommendations. All dog 
owners agreed to include their dogs in the study and signed 
an informed consent form before sample collection.
Results
Table 2 summarizes the sera panel results of the two 
evaluated RDTs discriminated by the clinical status with 
the parasitological and/or PCR results as gold standard, 
while in Table 3 we used latent class analysis (LCA) as 
reference standard. Table 4 shows the results of DPP per-
formance using rK39-RDT results as standard. Regarding 
to cross-reactivity, just one of sera diagnosed previously 
with Leptospira sp. infection reacted with DPP.
Table 5 shows the sensitivities and specificities of the 
sera sampled in Oberá city according to the clinical status 
and with the parasitological and/or PCR result as reference 
standard. The clinical status of the infected dogs (n = 143) 
were asymptomatic, (n = 77, 53.9%), symptomatic (n = 56, 
39.2%), while 10 dogs (7.0%) were not clinically evaluated 
(n = 10, 7.0%). The PCR-RFLPs positive from splenic 
aspirates (n = 21) or sequenced positive PCR from splenic 
aspirates (n = 14) were identified as Leishmania infantum. 
The kappa indexes between rK39-RDT and DPP was 
0.838 in the sera panel (Table 4), while in field conditions 
it was 0.685 (Table 5).
The estimated overall prevalence of CVL in dogs 
from dwellings of two neighbors of high transmission 
in Oberá city was 28% (95% CI: 24.0-32.1). This value 
was computed assuming as ‘infected’ sero-reactive dogs 
those with positive rK39-RDT and DPP, or dogs with one 
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of them positive and positive by parasitological or PCR 
tests, and ‘non-infected’ dogs with both negative rK39 and 
DPP, or dogs with one of them negative and negative by 
parasitological and PCR tests (inconclusive results as 
rK39-DPP results/no parasitological nor PCR, negative 
parasitological without PCR, or negative PCR without 
parasitological were excluded (n = 52)). 
Discussion
Using a panel of well characterized sera and parasitologi-
cal or molecular diagnosis as reference standards, both 
rapid diagnostic tests evaluated showed an overall good 
sensitivity and specificity (Table 6). DPP and rK39-RDT 
had a very good agreement between them with a Kappa 
TABLE 2.– Sensitivities and specificities of DPP and rK39-RDT tests for detection 
of anti-Leishmania antibodies in canine sera panel using parasitological or PCR test 
positive samples as standard reference for sensitivity (n = 267)*
 DPP rK39-RDT
 Estimate (95%CI) Estimate (95%CI)
Sensitivity     
 overall 93.3 (85.9; 97.5) 89.9 (81.7; 95.3)
 symptomatic 98.3 (91.1; 100) 93.3 (83.8; 98.2)
 asymptomatic 82.8 (64.2; 94.2) 82.8 (64.2; 94.2)
Specificity     
 overall 97.8 (94.3; 99.4) 98.9 (96.0; 99.9)
 other infections, non VL 93.3 (85.9; 97.5) 100.0 (95.3; 100)
 without other infections 98.0 (93.0; 99.8) 98.0 (93.0; 99.8)
*McNemar´s test to compare sensitivity and specificity between DPP and rK39-RDT was not 
significant (p>0.05) in all cases
TABLE 3.– Sensitivities and specificities of DPP and rK39-RDT tests for detection 
of anti-Leishmania antibodies in canine sera panel using Latent Class Analysis as 
standard reference (n=431)*
 DPP rK39-RDT
 Estimate (95%CI) Estimate (95%CI)
Sensitivity
 overall 100 (97.4; 100) 99.3 (96.0; 100)
 symptomatic 100 (95.8; 100) 98.8 (93.7; 100)
 asymptomatic 100 (93.2; 100) 100 (93.2; 100)
Specificity     
 overall 95.6 (92.5; 97.6) 93.9 (90.5; 96.3)
 other infections, non VL 97.4 (90.9; 99.7) 100 (95.3; 100)
 without other infections 95.3 (91.3; 97.8) 99 (96.3; 99.9)
*McNemar´s test to compare sensitivity and specificity between DPP and rK39-RDT was not 
significant (p>0.05) in all cases
TABLE 4.– Sensitivities and specificities of DPP test for 
detection of anti-Leishmania antibodies in canine sera panel 
using rK39-RDT as standard reference (n = 431)
  Estimate (95%CI)
Sensitivity
 overall 88.4  (82.3; 93.0)
 symptomatic 94.4 (91.6; 97.2)
 asymptomatic 80.0 (68.2; 88.9)
Specificity  
 overall 94.9  (91.6-97.2)
 other infections, non VL 97.4  (90.9; 99.7)
 without other infections 95.3 (91.2; 97.8)
Kappa index = 0.838
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agreement index of 0.83, although the sensitivity of DPP 
taking into account rK39-RDT positives was 88.4% 
(95%CI: 82.3; 93.0). 
When the performance of the RDT tests was evaluated 
in the field, with a broader spectrum of cases, the speci-
ficity remains in the same range than the results with the 
sera panel (Table 6), but the overall sensitivity dropped 
due to the low performance of rK39-RDT ≈ 77%, and so 
the Kappa agreement index between the tests was 0.68, 
barely substantial. The results with dog populations in 
actual field scenarios are sensitive to the uncontrolled 
variables as the prevalence rate; in Brazil the Kappa index 
between DPP and rK39-RDT was 0.87 in a low transmis-
sion area (Spírito Santo State), but 0.54 in a high endemic 
area (Piauí State)6. Further, the interpretation of tests by 
multiple operators, taking as negative some weak signals 
mainly from asymptomatic dog samples, could decrease 
the sensitivity of the tests. This fact highlights the operator-
dependent risk of bias when RDTs are used by agents in 
wide program activities, and so the need for standardized 
procedures, capacitation and quality control.
The performances obtained in this study are compa-
rable with the results obtained by other authors (Table 6). 
However, the sensitivity of RK39-RDT in much lower in 
some reports due to protocol differences as cohort studies 
or convenience sampling, and sera conservation proce-
dures15, or the tests were performed with different brands 
of dipsticks16, 17, 19. The disparate results reported for DPP 
were explained by cross-reactions mainly in asymptomatic 
dogs7,21 and possible false positives in the gold standard25. 
As it was discussed above for the Kappa agreement index 
the specificity varies according the transmission scenarios 
from 74% to 98% for rK39-RDT and from 60% to 98% for 
DPP (Table 6)6. 
Therefore, the difference in the literature about CVL 
RDTs sensitivity, specificity and confidence interval am-
plitudes may be related both to methodological issues13-16 
and biological ones, besides the possible differences 
in parasite species/strains-geographical settings. Ac-
cording to the gold standard or the tests taken as true 
positive the sensitivity could vary from 15% to 26%22. On 
the other hand, among the biological-based differences 
between studies, population and individual variables 
may modulate the performance of the test as genetic 
profile of dogs, socio-epidemiological context (life quality 
and immunocompromise), prevalence rate, time since 
infection, antibody titre, parasite load, clinical score and 
infectiousness8, 15. 
The cross-reactions reported are: rK39-RDT DiaMed-
Vet-IT with Neospora caninum in 1 out of 9 sera, Hepa-
tozoon canis 1/226, and human malaria 1/5527; rK39-RDT 
InBios Ehrlichia sp. 1/3 and Trypanosoma cruzi 3/1228; 
DPP with L. braziliensis 1/2 and 3/9, L. amazonensis 
2/27, 29, Babesia sp. 4/921, Leptospira sp. 1/13 in our study. 
Other authors did not found cross-reactions of DPP or 
rK39-RDT with Ehrlichia sp. or Babesia sp. 30. Therefore, 
besides the lack of information in same articles about 
differential diagnosis to discard double infections, there 
are also many inconsistencies about cross-reactions 
that may be due to the stage of infection-immunity of the 
control cases and common epitopes or precipitation of 
unspecific immunocomplexes. Anyway, there are more 
reports of cross-reactions with DPP than with rK39-RDT, 
and thus the reactivity with other species of Leishmania 
that also infect dogs in sympatric scenarios requires further 
investigation. 
In conclusion, the performance of rK39-RDT and DPP 
for CVL diagnosis is comparable and acceptable at least 
for symptomatic dogs when tested in scenarios of visceral 
leishmaniasis recent southern spread in Argentina. CVL 
RDTs are more portable for point of care diagnosis, have 
lower costs and are simpler, have quicker results, improve 
TABLE 5.– Sensitivities and specificities of DPP and rK39-RDT tests for detection 
of anti-Leishmania antibodies in canine sera from field sampling (Oberá city) using 
parasitological or PCR test positive samples as standard reference (n = 511)
  DPP rK39-RDT p*
 Estimate (95%CI) Estimate (95%CI) 
Sensitivity     
 overall 93.7 (88.4-97.1)  76.9 (69.1-83.6) < 0.001
 symptomatic 98.2 (90.4-100)  80.4 (67.6-89.8) < 0.001
 asymptomatic 92.2 (83.8-97.1)  71.4 (60.0-81.2) 0.003
Specificity 95.9 (93.4-97.7)  98.6 (96.9-99.6) 0.03
Kappa index = 0.685  
*McNemar´s test to compare sensitivity and specificity between DPP and rK39-RDT
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the compliance of dog owners and the relationship with 
the communities12. However, the statement of accept-
ability should be contextualized according the purpose 
of the test, from clinical diagnosis (individual-based), to 
seroprevalence studies (population-based) or outbreak 
control tools (decision making). In this sense, the evalu-
ated RDTs do not discriminate between infection and 
immunity, involving pre-clinical and recently infected 
dogs, and chronic individuals who solved the infection 
but remain with immune memory 6. Therefore, both RDTs, 
are still acceptable for program dog population-based 
studies as spatial stratification, focus intervention and 
follow up, dog individual screening and confirmation of 
clinical presumptive CVL diagnosis in polysimptomatic 
dogs. However, the sensitivity to detect asymptomatic 
and even to discriminate among symptomatic the most 
infectious ones (core-transmitters/super-spreaders) is 
not enough for operational programs15,31 , in order to tar-
get reservoir-based control interventions, mainly in high 
prevalence settings. Immunological tests in combination 
with other non-immunological based tests will be required 
for highly sensitive/specific diagnosis of infected dogs with 
L. infantum, for reservoir management both from public 
health and individual animal health perspectives.
Conflict of interest: None to declare
TABLE 6.– Reported overall sensitivities, sensitivities in symptomatic (S symp) and 
asymptomatic (S asympt) populations, and specificities (Spec) of DPP and rK39-RDT 
tests for detection of anti-Leishmania antibodies 
 Sensit S symp S asymp Spec  Ref.
Rk39-RDT/DPP     
 92-100 96.0 83.0 98-95 Argentina *
 87.5 89.0 82.0 97.0 Argentina **
Rk39-RDT/      
Human VL 93.9   95.3 World 15
 84.7   96.8 Brazil 12,13
Canine VL 89.6    World 15
 64.7 66.7 55.6  Argentina 15 a
 88.0 90.0 77.0 74-98 Brazil 6
 96.0   100 Brazil 18
 46.3 76.9 33.3 100 Brazil 15 b 
 72-77   61-75 Brazil 16 c
 55.2 60.0 33.3  Brazil 17d
 91.5   94.7 Brazil 19 e
DPP      
Canine VL 93.0   92.0 Brazil 20
 86.0   94.0 Brazil 9
 90.6 89.4 92.1 95.1 Brazil 21
 21.4   92.6 Brazil 23
 81.3 76.2 23,8 72.4 Brazil 24
 87.5-88 100 72.7 68.2-73.3 Brazil 25
 72.5 98.0 47.0 96.0 Brazil 7
 89.0 89.9 75.0 70.2 Brazil 5
 98.0 98.0 100 60-98 Brazil 6
* This study: Sera panel, mean of DPP and rK39-RDT results 
** This study; Field performance, mean of DPP and rK39-RDT results
aCruz I, Acosta L, Gutierrez MN, Nieto J, Canavate C, et al. (2010) A canine leishmaniasis pilot survey 
in an emerging focus of visceral leishmaniasis: Posadas (Misiones, Argentina). BMC Infect Dis 10: 34, 
re-analized by 15
bCohort study
cLeishmania RAPYDTEST; Intersep, Wokingham, United Kingdom
dSensit Leishmania rK39 Ubio Biotechnology Systems Pvt Ltd, Cochin Kerala, India. 
erK39 immunochromatography non specified brand
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LA TAPA
Colchicum autumnale - Hans-Simon Holtzbecker (m. 1671)
Colchicum autumnale. Del Gottorfer Codex (1649 al 1659). Hans-Simon Holtzbecker (m. 
1671). Gouache sobre pergamino. Fuente: https://commons.wikimedia.org/wiki/File:Gc23_col-
chicum_autumnale.jpg
Libro encargado a Holtzbecker por el Duque de Gottorp para ilustrar las flores del jardín de su 
castillo (Palacio de Gottorp, Schleswig, Alemania). Son cuatro volúmenes, 365 páginas ilustran 
1180 plantas (50 × 38 cm). El Codex se encuentra en la Royal Collection of Graphic Art de la SMK 
- National Gallery of Denmark, Copenhague, Dinamarca. La restauración para exhibir y digitalizar 
las páginas puede apreciarse en: https://www.youtube.com/watch?v=JLtWrWT0mAs. El artista 
era nativo de Hamburgo y se le atribuyen cuatro florilegios, uno de ellos, el Moller Florilegium, se 
remató en Christie’s, Londres, por 551 500 libras (GBP) en 1999.
El bulbo del cólquico (syn: mataperros, azafrán bastardo, etc.), se usó desde tiempo inmemo-
rial para tratar la inflamación, los dolores articulares, y la gota. Ahora sus usos son más amplios 
(Dasgeb B, Kornreich D, McGuinn K, Okon L, Brownell I, Sackett DL. Colchicine: an ancient drug 
with novel applications. Br J Dermatol 2018; 178: 350-6. doi:10.1111/bjd.15896). Más aún, se han 
publicado los resultados del Colchicine Cardiovascular Outcomes Trial (COLCOT), que probó do-
sis bajas de colchicina en la prevención secundaria después del infarto de miocardio (Tardif J-C, 
Kouz S, Waters et al. Efficacy and safety of low-sose xolchicine after myocardial infarction. N Engl 
J Med 2019; 381: 2497-505). Como sugiere una editorialista, mantengamos la cautela. (Newby 
LK. Inflammation as a treatment target after acute myocardial infarction. N Engl J Med 2019; 381: 
2562-63). Y más cuando leemos la declaración de conflictos de interés.
El agente activo del cólquico es la colchicina, remedio o veneno, según la dosis. La colchicina 
bloquea las mitosis en metafase porque cuando se une a las tubulinas, altera su conformación 
e impide el ensamblaje de los microtúbulos y el huso mitótico. Este efecto sobre las células fue 
descubierto por R. Pernice, patólogo siciliano que publicó su trabajo en una inalcanzable revista 
siciliana. Al lector curioso puede interesarle el editorial de Gerald Weissmann titulado Medea and 
the Microtubule: Research has been translational ever since colchis, erudito, entretenido y pleno 
de información. (Faseb J 2009; 23: 2761-94).
